Cargando…
Jumonji AT-rich interactive domain 1B overexpression is associated with the development and progression of glioma
Previous studies have suggested that jumonji AT-rich interactive domain 1B (JARID1B) plays an important role in the genesis of some types of cancer, and it is therefore considered to be an important drug target protein. Although the expression of JARID1B has been researched in some types of cancer,...
Autores principales: | FANG, LIPING, ZHAO, JIUHAN, WANG, DAN, ZHU, LIYU, WANG, JIAN, JIANG, KUI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899035/ https://www.ncbi.nlm.nih.gov/pubmed/27246838 http://dx.doi.org/10.3892/ijmm.2016.2614 |
Ejemplares similares
-
Jumonji AT-rich interactive domain 1B overexpression is associated with the development and progression of glioma
por: Fang, Liping, et al.
Publicado: (2016) -
Reduced Expression of Jumonji AT-Rich Interactive Domain 2 (JARID2) in Glioma Inhibits Tumor Growth In Vitro and In Vivo
por: Li, Zhenjiang, et al.
Publicado: (2017) -
Jumonji domain-containing protein RIOX2 is overexpressed and associated with worse survival outcomes in prostate cancers
por: He, Chenchen, et al.
Publicado: (2023) -
Jumonji AT-rich interactive domain 1B promotes the growth of pancreatic tumors via the phosphatase and tensin homolog/protein kinase B signaling pathway
por: Shen, Xudong, et al.
Publicado: (2018) -
Jumonji AT-rich interactive domain 1B promotes the growth of pancreatic tumors via the phosphatase and tensin homolog/protein kinase B signaling pathway
por: Shen, Xudong, et al.
Publicado: (2023)